Published in FEMS Microbiol Lett on January 01, 1990
Clonal diversity of Streptococcus mitis biovar 1 isolates from the oral cavity of human neonates. Clin Diagn Lab Immunol (1996) 1.30
Ability to bind salivary alpha-amylase discriminates certain viridans group streptococcal species. J Clin Microbiol (1990) 1.19
Characterization of an amylase-binding component of Streptococcus gordonii G9B. Infect Immun (1992) 1.15
Use of restriction fragment polymorphism analysis of rRNA genes to assign species to unknown clinical isolates of oral viridans streptococci. J Clin Microbiol (1994) 1.06
Prevalence of the amylase-binding protein A gene (abpA) in oral streptococci. J Clin Microbiol (1999) 1.02
RegG, a CcpA homolog, participates in regulation of amylase-binding protein A gene (abpA) expression in Streptococcus gordonii. J Bacteriol (2001) 1.00
Taking the starch out of oral biofilm formation: molecular basis and functional significance of salivary α-amylase binding to oral streptococci. Appl Environ Microbiol (2012) 0.98
Species identification of oral viridans streptococci by restriction fragment polymorphism analysis of rRNA genes. J Clin Microbiol (1993) 0.94
Identification and characterization of amylase-binding protein C from Streptococcus mitis NS51. Mol Oral Microbiol (2010) 0.91
Clonal diversity and turnover of Streptococcus mitis bv. 1 on shedding and nonshedding oral surfaces of human infants during the first year of life. Clin Diagn Lab Immunol (2005) 0.89
Physiological and serological variation in Streptococcus mitis biovar 1 from the human oral cavity during the first year of life. Arch Oral Biol (2006) 0.88
A streptococcal adhesion system for salivary pellicle and platelets. Infect Immun (1998) 0.82
Implications of salivary protein binding to commensal and pathogenic bacteria. J Oral Biosci (2013) 0.76
Comparative genomics and evolution of the amylase-binding proteins of oral streptococci. BMC Microbiol (2017) 0.75
Evolution of penicillin resistance in Streptococcus pneumoniae; the role of Streptococcus mitis in the formation of a low affinity PBP2B in S. pneumoniae. Mol Microbiol (1993) 3.05
A scheme for the identification of viridans streptococci. J Med Microbiol (1991) 2.77
Genetic relatedness within and between serotypes of Streptococcus pneumoniae from the United Kingdom: analysis of multilocus enzyme electrophoresis, pulsed-field gel electrophoresis, and antimicrobial resistance patterns. J Clin Microbiol (1996) 2.32
Genetic approaches to the identification of the mitis group within the genus Streptococcus. Microbiology (1999) 2.30
Intermedilysin, a novel cytotoxin specific for human cells secreted by Streptococcus intermedius UNS46 isolated from a human liver abscess. Infect Immun (1996) 1.65
Beta haemolytic streptococci: single colony grouping by a rapid, simplified coagglutination technique. Med Lab Sci (1984) 1.53
Distribution of the intermedilysin gene among the anginosus group streptococci and correlation between intermedilysin production and deep-seated infection with Streptococcus intermedius. J Clin Microbiol (2000) 1.45
Biochemical identification of the enterobacteriaciae using a multipoint inoculation system. Med Lab Sci (1983) 1.44
Species of alpha-hemolytic streptococci possessing a C-polysaccharide phosphorylcholine-containing antigen. Infect Immun (1993) 1.42
Streptococcus crista sp. nov., a viridans streptococcus with tufted fibrils, isolated from the human oral cavity and throat. Int J Syst Bacteriol (1991) 1.42
Identifying non-capsulate strains of Streptococcus pneumoniae isolated from eyes. J Clin Pathol (1986) 1.37
Conservation of the gene encoding streptococcal antigen I/II in oral streptococci. Infect Immun (1991) 1.36
Sialidase activity of the "Streptococcus milleri group" and other viridans group streptococci. J Clin Microbiol (1990) 1.27
PCR-Based methods for genotyping viridans group streptococci. J Clin Microbiol (1999) 1.25
Antimicrobial effect of a novel ozone- generating device on micro-organisms associated with primary root carious lesions in vitro. Caries Res (2000) 1.24
Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin. Antimicrob Agents Chemother (1993) 1.18
A simple biochemical scheme for the differentiation of Streptococcus mutans and Streptococcus sobrinus. Caries Res (1991) 1.11
Antimicrobial susceptibility testing and biochemical identification using multipoint inoculation: 5 years' experience. Med Lab Sci (1988) 1.06
Production of specific glycosidase activities by Streptococcus intermedius strain UNS35 grown in the presence of mucin. J Med Microbiol (1994) 1.05
Occurrence of lipoteichoic acid in oral streptococci. Int J Syst Bacteriol (1997) 0.99
Classification and overview of the genera Streptococcus and Enterococcus. Soc Appl Bacteriol Symp Ser (1997) 0.99
Evaluation of Malthus 128H microbiological growth analyser for detecting significant bacteriuria. J Clin Pathol (1985) 0.95
Identification of Enterobacteriaceae: report of the British Society for Multipoint Technology collaborative study. Med Lab Sci (1989) 0.95
A computerised spreadsheet for audit of a microbiology laboratory. Med Lab Sci (1991) 0.94
Mannosidase production by viridans group streptococci. J Clin Microbiol (2001) 0.92
Effect on polymorphonuclear cell function of a human-specific cytotoxin, intermedilysin, expressed by Streptococcus intermedius. Infect Immun (2001) 0.87
Intermedilysin. A cytolytic toxin specific for human cells of a Streptococcus intermedius isolated from human liver abscess. Adv Exp Med Biol (1997) 0.87
Proteolytic activity of oral streptococci. FEMS Microbiol Lett (1990) 0.87
DNA-DNA reassociation studies of Streptococcus constellatus with unusual 16S rRNA sequences. Int J Syst Evol Microbiol (2000) 0.87
Interactions between Eikenella corrodens and 'Streptococcus milleri-group' organisms: possible mechanisms of pathogenicity in mixed infections. Antonie Van Leeuwenhoek (1996) 0.82
Chondroitin sulfate depolymerase and hyaluronidase activities of viridans streptococci determined by a sensitive spectrophotometric assay. J Clin Microbiol (1993) 0.82
Comparative efficacy of oral doses of clindamycin and erythromycin in the prevention of bacteraemia. Br Dent J (1995) 0.81
Taxonomic study of "tufted mitior" strains of streptococci (Streptococcus sanguinis biotype 11); recognition of a new genospecies. Syst Appl Microbiol (2000) 0.79
High incidence of group C streptococci isolated from throat swabs. J Clin Pathol (1985) 0.78
A numerical taxonomic study of the "Streptococcus milleri" group based upon conventional phenotypic tests and pyrolysis mass spectrometry. J Med Microbiol (1992) 0.76
Axial mode structure of a copper vapor pumped dye laser. Appl Opt (1977) 0.75
Effects of different acidulants on growth of 'Streptococcus milleri group' strains isolated from various sites of the human body. Lett Appl Microbiol (1995) 0.75
The relationship between glycosyltransferase production and membrane fatty acid composition of Streptococcus sanguis NCTC 7865 grown in the presence of protonmotive force inhibitors. J Gen Microbiol (1987) 0.75